CEO
Accelerating drug development with AI-enabled technology
Jo Varshney
San Francisco
2018
VeriSIM creates AI-driven bio-simulation models in order to test promising drug candidates for availability, toxicity, and efficacy in computers before expensive and time-consuming animal testing. Right now, 92% of compounds fail to make it through animal testing, and VeriSIM allows researchers to anticipate success -- and failure -- far more cost- and time-effectively. Researchers will be able to test thousands of potential drug candidates, saving them time and money, and increasing the likelihood that human clinical trials will be more successful. Millions of dollars will be saved, and potentially even more lives.
Jo Varshney
San Francisco
2018
VeriSIM creates AI-driven bio-simulation models in order to test promising drug candidates for availability, toxicity, and efficacy in computers before expensive and time-consuming animal testing. Right now, 92% of compounds fail to make it through animal testing, and VeriSIM allows researchers to anticipate success -- and failure -- far more cost- and time-effectively. Researchers will be able to test thousands of potential drug candidates, saving them time and money, and increasing the likelihood that human clinical trials will be more successful. Millions of dollars will be saved, and potentially even more lives.
